Kymera Therapeutics Inc (KYMR) — Financial Flexibility Index
Kymera Therapeutics Inc (KYMR) has a Financial Flexibility Index of -0.38x as of June 2026. Free cash flow of $-53.59 Million (operating CF $-54.06 Million minus capex $473.00K) represents 0% of total liabilities ($139.85 Million). Check Kymera Therapeutics Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Kymera Therapeutics Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Kymera Therapeutics Inc across 8 annual periods. For the full cash flow conversion analysis, see KYMR operating cash flow.
Annual Financial Flexibility Index for Kymera Therapeutics Inc (2018–2025)
Year-by-year free cash flow to debt coverage for Kymera Therapeutics Inc. Explore Kymera Therapeutics Inc (KYMR) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.42x | $-231.44 Million | $-232.89 Million | $163.15 Million | ▼ -11.2% |
| 2024 | -1.28x | $-181.66 Million | $-194.50 Million | $142.42 Million | ▼ -237.4% |
| 2023 | -0.38x | $-68.35 Million | $-102.83 Million | $180.79 Million | ▲ +71.6% |
| 2022 | -1.33x | $-150.25 Million | $-153.09 Million | $112.98 Million | ▼ -52.7% |
| 2021 | -0.87x | $-127.35 Million | $-128.95 Million | $146.27 Million | ▼ -282.0% |
| 2020 | 0.48x | $97.23 Million | $88.13 Million | $203.29 Million | ▲ +395.7% |
| 2019 | 0.10x | $18.44 Million | $17.91 Million | $191.11 Million | ▲ +146.0% |
| 2018 | -0.21x | $-16.51 Million | $-17.86 Million | $78.67 Million | — |